• Karyopharm stock trades steadily as investors watch Selinexor franchise AD HOC NEWS Thu, 09 Jul 2026 16:14:55 GMT
• RBC Capital Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Maintains Target Price $16 Moomoo Thu, 09 Jul 2026 08:05:42 GMT
• Karyopharm Therapeutics faces a data setback as investors weigh late-stage cancer pipeline AD HOC NEWS Tue, 07 Jul 2026 19:37:26 GMT
• Karyopharm Therapeutics outlines its oncology focus as KPTI stock trades on Nasdaq AD HOC NEWS Fri, 03 Jul 2026 15:10:27 GMT
• karyopharm therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4) AOL.com Thu, 02 Jul 2026 06:46:01 GMT
• Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire Wed, 01 Jul 2026 20:05:00 GMT
• Karyopharm gives 4 new hires stock awards vesting over 3 years Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:44:05 GMT
• Karyopharm Therapeutics Inc.(NasdaqGS: KPTI) added to Russell 3000E Index marketscreener.com Mon, 29 Jun 2026 06:31:07 GMT
• Karyopharm Therapeutics Inc.(NasdaqGS: KPTI) added to Russell 2500 Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Enterprise value to EBITDA forward of Karyopharm Therapeutics Inc. – NASDAQ:KPTI TradingView Sun, 28 Jun 2026 12:29:54 GMT
• price to sales forward of karyopharm therapeutics inc. – nasdaq:kpti TradingView Sun, 28 Jun 2026 10:32:58 GMT
• enterprise value to ebit forward of karyopharm therapeutics inc. – nasdaq:kpti TradingView Sun, 28 Jun 2026 06:17:20 GMT
• karyopharm therapeutics (kpti) stock price, news & analysis $kpti MarketBeat Fri, 26 Jun 2026 07:00:00 GMT
• karyopharm therapeutics, inc. actuals & estimates (nasdaq:kpti) TradingView Thu, 25 Jun 2026 17:28:06 GMT
• Karyopharm Therapeutics (KPTI) Stock Sees Split Analyst Revisions After Phase 3 Trial Update Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 20:37:02 GMT
• karyopharm therapeutics inc (kpti) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 13:20:21 GMT
• karyopharm therapeutics inc (kpti) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:15:48 GMT
• karyopharm therapeutics inc (kpti) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:15:40 GMT
• karyopharm therapeutics inc (kpti) institutional confidence TradingKey Thu, 18 Jun 2026 08:50:41 GMT
• Karyopharm: Xpovio Revenue Stagnation And Toxicity Concerns Justify Sell Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Maintains Target Price $13 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• H.C. Wainwright reiterates Karyopharm stock rating on trial data By Investing.com Investing.com Nigeria Thu, 18 Jun 2026 07:00:00 GMT
• Karyopharm Therapeutics Inc (KPTI) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 01:24:52 GMT
• karyopharm therapeutics inc (kpti) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 01:22:24 GMT
• karyopharm therapeutics inc (kpti) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 00:53:57 GMT
• Karyopharm Therapeutics Inc (KPTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 00:52:26 GMT
• h.c. wainwright maintains karyopharm therapeutics(kpti.us) with buy rating, maintains target price $13 Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• karyopharm therapeutics secures eha congress acclaim for late-breaking sentry trial update Traders Union Sun, 14 Jun 2026 13:25:32 GMT
• cantor fitzgerald reiterates overweight on karyopharm stock by investing.com Investing.com India Tue, 09 Jun 2026 07:00:00 GMT
• How The Investment Story Is Evolving For Karyopharm Therapeutics (KPTI) Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• T. Rowe Price (KPTI) files Schedule 13G/A showing 6.6% position Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption TradingView Thu, 04 Jun 2026 07:00:00 GMT
• cantor fitzgerald reiterates karyopharm stock rating on trial outlook Investing.com Thu, 04 Jun 2026 02:13:58 GMT
• karyopharm to participate in webcast featuring endometrial cancer key opinion leader on june 8, 2026 Karyopharm Wed, 03 Jun 2026 22:53:57 GMT
• cancer expert joins karyopharm's june 8 investor webcast Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• karyopharm therapeutics inc. (kpti) discusses phase iii sentry trial results of selinexor plus ruxolitinib in myelofibrosis - slid... Seeking Alpha Tue, 02 Jun 2026 20:42:40 GMT
• kpti: karyopharm's abstract accepted for presentation at europea GuruFocus Tue, 02 Jun 2026 19:52:30 GMT
• kpti: karyopharm announces positive phase 3 sentry trial results GuruFocus Tue, 02 Jun 2026 18:10:52 GMT
• karyopharm phase 3 myelofibrosis data selected for top eha session grafa.com Tue, 02 Jun 2026 17:48:51 GMT
• karyopharm to report data from phase 3 trial of selinexor plus ruxolitinib in myelofibrosis marketscreener.com Tue, 02 Jun 2026 15:23:01 GMT
• Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at E... PR Newswire Tue, 02 Jun 2026 07:00:00 GMT
• Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Prese... PR Newswire Tue, 02 Jun 2026 07:00:00 GMT
• Karyopharm’s myelofibrosis trial selected for EHA presentation Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Karyopharm reports phase 3 myelofibrosis trial results at ASCO Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Drug combo nearly doubles spleen response in myelofibrosis trial Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• kpti: selinexor plus ruxolitinib nearly doubled spleen response and improved survival in myelofibrosis TradingView Tue, 02 Jun 2026 07:00:00 GMT
• cancer trial suggests spleen shrinkage may predict survival in myelofibrosis Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• karyopharm therapeutics presents results from phase 3 sentry trial of selinexor plus ruxolitinib in myelofibrosis marketscreener.com Tue, 02 Jun 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) to discuss sentry trial results i GuruFocus Mon, 01 Jun 2026 18:07:40 GMT
• Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire Mon, 01 Jun 2026 07:00:00 GMT
• Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2... PR Newswire Mon, 01 Jun 2026 07:00:00 GMT
• Myelofibrosis Phase 3 trial data to be detailed on June 2 call Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• New Karyopharm hire receives 1,200 restricted stock units Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Karyopharm to host call on phase 3 myelofibrosis trial results Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• karyopharm shares rise 10% after mixed phase 3 sentry trial results MSN Sun, 31 May 2026 05:24:46 GMT
• wall street analysts think karyopharm therapeutics (kpti) could surge 70.46%: read this before placing a bet MSN Sun, 31 May 2026 04:52:41 GMT
• karyopharm therapeutics (kpti) holds near $9.10 amid low-volume consolidation - percent below ma newsline.com Sat, 30 May 2026 07:00:00 GMT
• kpti stock price, quote & chart | karyopharm therapeutics inc (nasdaq:kpti) ChartMill Fri, 29 May 2026 07:00:00 GMT
• karyopharm to speak at 2026 jefferies global healthcare conference Intellectia AI Thu, 28 May 2026 12:27:57 GMT
• cancer drug maker karyopharm joins 2026 jefferies healthcare summit Stock Titan Thu, 28 May 2026 07:00:00 GMT
• karyopharm to participate at the 2026 jefferies global healthcare conference Karyopharm Thu, 28 May 2026 07:00:00 GMT
• karyopharm (nasdaq: kpti) boosts share plans and grants ceo psu awards Stock Titan Thu, 28 May 2026 07:00:00 GMT
• Wall Street Analysts Think Karyopharm Therapeutics (KPTI) Could Surge 70.46%: Read This Before Placing a Bet Zacks Investment Research Wed, 27 May 2026 07:00:00 GMT
• karyopharm therapeutics teases asco sentry data as fda path comes into focus Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• karyopharm (kpti) director christy oliger receives 15,508 rsu equity award Stock Titan Tue, 26 May 2026 07:00:00 GMT
• karyopharm therapeutics spotlights selinexor milestones, asco data and cancer trial readouts Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• chen schor of karyopharm (kpti) receives 15,508 rsu award Stock Titan Tue, 26 May 2026 07:00:00 GMT
• karyopharm (kpti) director awarded 15,508 rsus vesting in 2027 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) director receives 15,508 rsus in equity award Stock Titan Tue, 26 May 2026 07:00:00 GMT
• karyopharm (kpti) director receives 15,508 rsu equity award vesting in 2027 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• karyopharm (nasdaq: kpti) director gets 15,508 rsus vesting in 2027 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting PA Media Mon, 25 May 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) posts gains: bounces from support, tests key resistance - range breakout newsline.com Fri, 22 May 2026 07:00:00 GMT
• kpti stock price, quote & chart | karyopharm therapeutics inc (nasdaq:kpti) ChartMill Fri, 22 May 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) edges higher as key technical levels come into focus - etf aum growth newsline.com Thu, 21 May 2026 07:00:00 GMT
• karyopharm therapeutics stock (us48576u1060): clinical updates and cash focus after recent data and AD HOC NEWS Thu, 21 May 2026 04:22:55 GMT
• karyopharm rises on securing $100m in financing to extend cash runway into q2 2026 MSN Wed, 20 May 2026 22:25:37 GMT
• kpti technical analysis | trend, signals & chart patterns | karyopharm therapeutics inc (nasdaq:kpti) ChartMill Wed, 20 May 2026 07:00:00 GMT
• earnings call transcript: karyopharm q1 2026 results disappoint, stock drops Investing.com Wed, 20 May 2026 04:09:41 GMT
• karyopharm rises on securing $100m in financing to extend cash runway into q2 2026 MSN Tue, 19 May 2026 20:16:53 GMT
• karyopharm therapeutics (kpti) reports q1 loss, beats revenue estimates MSN Tue, 19 May 2026 07:45:48 GMT
• earnings call transcript: karyopharm q1 2026 results disappoint, stock drops Investing.com Tue, 19 May 2026 07:00:00 GMT
• FDA’s April approvals include slimmer label for Xpovio, two NMEs and a gene therapy BioCentury Mon, 18 May 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) price target increased by 13.33% to 13.87 MSN Sun, 17 May 2026 23:56:40 GMT
• karyopharm therapeutics stock (us48666t1097): cancer drug developer in focus after recent biotech ne AD HOC NEWS Sun, 17 May 2026 14:34:29 GMT
• karyopharm shares rise 10% after mixed phase 3 sentry trial results MSN Sun, 17 May 2026 12:13:30 GMT
• karyopharm therapeutics inc. - common stock (nq: kpti FinancialContent Sun, 17 May 2026 06:14:33 GMT
• rbc capital remains a buy on karyopharm therapeutics (kpti) The Globe and Mail Sat, 16 May 2026 07:00:00 GMT
• karyopharm therapeutics (kpti) price target increased by 13.33% to 13.87 MSN Sat, 16 May 2026 03:07:09 GMT
• opaleye management inc. reduces stake in karyopharm therapeutics inc. GuruFocus Sat, 16 May 2026 02:25:12 GMT
• karyopharm therapeutics (kpti) reports q1 loss, beats revenue estimates MSN Sat, 16 May 2026 01:52:01 GMT
• karyopharm therapeutics (kpti) quarterly loss deepens reinforcing bearish profitability concerns simplywall.st Sat, 16 May 2026 00:02:48 GMT
• karyopharm therapeutics reports q1 2026 results: full earnings call transcript Sahm Fri, 15 May 2026 10:05:50 GMT
• Karyopharm Therapeutics (KPTI) Quarterly Loss Deepens Reinforcing Bearish Profitability Concerns simplywall.st Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) schedule 13g: acorn entities and anders hove report 1.52m shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) ceo logs psu vesting and automatic tax-related share sale Stock Titan Fri, 15 May 2026 07:00:00 GMT
• karyopharm therapeutics inc. (nasdaq:kpti) q1 2026 earnings call transcript Insider Monkey Fri, 15 May 2026 07:00:00 GMT
• karyopharm therapeutics cao kristin abate sells $503 in stock Investing.com Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) evp nets psus, then small tax-driven share sale Stock Titan Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) evp sale covers tax on earned psu award Stock Titan Fri, 15 May 2026 07:00:00 GMT
• should you sell karyopharm therapeutics (kpti) after -13.82% drop? 2026-05-15 - fundamental weighted newsline.com Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) evp earns psu shares, sells 324 to cover taxes Stock Titan Fri, 15 May 2026 07:00:00 GMT
• karyopharm (kpti) cao reports psu vesting and small pre-planned tax sale Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ikarian capital (kpti) files joint 13g showing sub‑5% holding Stock Titan Fri, 15 May 2026 07:00:00 GMT
• [form 4] karyopharm therapeutics inc. insider trading activity Stock Titan Fri, 15 May 2026 07:00:00 GMT
• rbc capital maintains karyopharm therapeutics(kpti.us) with buy rating, maintains target price $16 Moomoo Fri, 15 May 2026 07:00:00 GMT
• kpti stock price, quote & chart | karyopharm therapeutics inc (nasdaq:kpti) ChartMill Fri, 15 May 2026 07:00:00 GMT
• karyopharm therapeutics inc (kpti) q1 2026 earnings call highlights: strong revenue growth and ... by gurufocus Investing.com Canada Fri, 15 May 2026 01:37:49 GMT
• karyopharm therapeutics inc (kpti) q1 2026 earnings call highlig GuruFocus Thu, 14 May 2026 23:11:05 GMT
• earnings call summary | karyopharm therapeutics(kpti.us) q1 2026 earnings conference 富途牛牛 Thu, 14 May 2026 23:01:24 GMT
• karyopharm therapeutics inc (kpti) stock price, quote, news & history Benzinga Thu, 14 May 2026 22:25:00 GMT
• karyopharm therapeutics inc. q1 2026 financial results and sec 10-q filing highlights Minichart Thu, 14 May 2026 20:01:00 GMT
• karyopharm shares rise 10% after mixed phase 3 sentry trial results MSN Thu, 14 May 2026 18:57:02 GMT
• karyopharm therapeutics reports q1 2026 results, advances selinexor phase 3 trials in myelofibrosis and endometrial cancer Minichart Thu, 14 May 2026 16:30:00 GMT
• is karyopharm therapeutics (kpti) overvalued after q1 2026 earni GuruFocus Thu, 14 May 2026 15:22:30 GMT
• kpti: strong q1 revenue, compelling sentry data, and solid liquidity position support 2026 outlook TradingView Thu, 14 May 2026 14:18:07 GMT
• kpti: strong q1 revenue, positive sentry trial results, and robust commercial outlook for 2026 TradingView Thu, 14 May 2026 13:19:37 GMT
• karyopharm therapeutics sets near term milestones in cancer and myelofibrosis pipelines after q1 update Traders Union Thu, 14 May 2026 13:15:01 GMT
• karyopharm therapeutics stock (us48576u1060): q1 revenue beats estimates, trial enrollment complete AD HOC NEWS Thu, 14 May 2026 12:26:07 GMT
• karyopharm therapeutics inc (nasdaq:kpti) posts q1 beat and highlights asco presentation, shares surge 7% ChartMill Thu, 14 May 2026 12:24:21 GMT
• karyopharm (nasdaq: kpti) posts q1 loss and warns on going concern Stock Titan Thu, 14 May 2026 11:45:56 GMT
Karyopharm Therapeutics Inc(NASDAQ:KPTI) 
Karyopharm Therapeutics Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is developing small molecule selective inhibitor of nu...
Website: http://www.karyopharm.com
Founded: 2008
Full Time Employees: 347
Sector: Healthcare
Industry: Biotechnology